-
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al DC CAFC
- 1:18-cv-01043
- D. Del.
- Judge: Kent A. Jordan
- Filed: 07/16/2018
- Closed: 10/20/2022
- Latest Docket Entry: 04/10/2024
- PACER
- Docket updated daily
1
Plaintiff
45
Defendants
1
Accused
Product
1
Patent-in-Suit
1,558
Days in
Litigation
-
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al DC CAFC
- 1:18-cv-01043
- D. Del.
- Judge: Kent A. Jordan
- Filed: 07/16/2018
- Closed: 10/20/2022
- Latest Docket Entry: 04/10/2024
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Alkem Laboratories Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 9,187,405 B2 |
1
|
Infringement
Entry 783
|
HEC Pharm Company Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 9,187,405 B2 |
1, 2, 3, 4, 5, 6
|
Infringement
Entry 780
|
HEC Pharm USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 9,187,405 B2 |
1, 2, 3, 4, 5, 6
|
Infringement
Entry 780
|
Mylan Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 9,187,405 B2 |
1
|
Infringement
Entry 804
|
